In the News

199 News Items found
Illustration of DNA base pairs
In the Lab
The multicenter project, which yielded dozens of scientific papers on more than 30 different kinds of cancer, has officially drawn to a close.
AACR 2019 Annual Meeting
In the News
Read up on the latest developments in several important areas of cancer research emerging from the 2019 American Association for Cancer Research annual meeting.
MSK acupuncturist Charles Rico is seen giving acupressure to patient Elizabeth Sosa at the MSK Ralph Lauren Center.
Learn how acupuncture is being used at the MSK Ralph Lauren Center in Harlem to reduce pain and other symptoms in people facing cancer.
A Fred’s Team runner giving a high five
Learn about how our donor community is funding life-changing cancer research at Memorial Sloan Kettering and ensuring a brighter future for people with cancer around the world.
Various kinds of nuts
In the Clinic
People who maintain a healthy lifestyle after surgery and chemotherapy for colon cancer are more likely to have a favorable outcome after treatment.
Dr. Wungki Park is seen smiling in a lab.
A new drug is showing very encouraging results against pancreatic cancer, thanks to clinical trials of daraxonrasib at MSK and other hospitals.
Memorial Sloan Kettering Alvin Goh, an expert in robotic surgery.
In the Clinic
MSK has expanded its bladder cancer surgery options with new robotic methods for constructing a substitute bladder.
Pattie Fuller smiles while wearing a pink plaid poncho
After immunotherapy and targeted therapy failed to bring a patient's melanoma under control, MSK doctors offered her a new treatment called tumor-infiltrating lymphocyte, or TIL, therapy.
MSK's Mark Awad, MD, PhD, is seen smiling.
Learn about the questions to ask a lung cancer doctor after being diagnosed, from an MSK specialist who has successfully treated many people for lung cancer.
(From left) David Scheinberg, Andrew Zelenetz, and Joseph Jurcic are using monoclonal antibodies to improve the treatment of patients with leukemia and lymphoma.
Therapies designed to target cancer while sparing healthy tissue show benefit, but have not yet reached full potential.